Form 4 for HQL abrdn Life Sciences Investors
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-11 · accession 0001104659-21-103959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-12 | 2021-08-11 | HQL | OMSTEAD DANIEL R | Pres, Dir | P - Purchase | $21.63 | +6,403 | 146.5K | +5% | +$138.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Beneficial Interest | 2021-08-11 | P | A | 6,403 | $21.63 | 146,489.44 | D | — | — |